| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma.
|
Hepatology
|
2008
|
1.07
|
|
2
|
HIF-1alpha: a valid therapeutic target for tumor therapy.
|
Cancer Res Treat
|
2004
|
1.06
|
|
3
|
In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia.
|
NMR Biomed
|
2011
|
1.01
|
|
4
|
Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats.
|
J Pineal Res
|
2010
|
0.92
|
|
5
|
The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway.
|
Biomaterials
|
2010
|
0.92
|
|
6
|
Folate-based near-infrared fluorescent theranostic gemcitabine delivery.
|
J Am Chem Soc
|
2013
|
0.90
|
|
7
|
Synthesis and high performance of magnetofluorescent polyelectrolyte nanocomposites as MR/near-infrared multimodal cellular imaging nanoprobes.
|
ACS Nano
|
2011
|
0.88
|
|
8
|
Magnetic resonance imaging of superparamagnetic iron oxide-labeled macrophage infiltrates in acute-phase renal ischemia-reperfusion mouse model.
|
Nanomedicine
|
2011
|
0.88
|
|
9
|
HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
|
Cancer Lett
|
2011
|
0.88
|
|
10
|
Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis.
|
J Med Chem
|
2011
|
0.86
|
|
11
|
Therapeutic potential of human induced pluripotent stem cells in experimental stroke.
|
Cell Transplant
|
2012
|
0.86
|
|
12
|
Noninvasive assessment of myocardial inflammation by cardiovascular magnetic resonance in a rat model of experimental autoimmune myocarditis.
|
Circulation
|
2012
|
0.85
|
|
13
|
An activatable theranostic for targeted cancer therapy and imaging.
|
Angew Chem Int Ed Engl
|
2014
|
0.84
|
|
14
|
Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells.
|
Cancer Lett
|
2011
|
0.83
|
|
15
|
Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells.
|
Cancer Lett
|
2013
|
0.82
|
|
16
|
Development of new fluorescent xanthines as kinase inhibitors.
|
Org Lett
|
2010
|
0.82
|
|
17
|
An activatable prodrug for the treatment of metastatic tumors.
|
J Am Chem Soc
|
2014
|
0.81
|
|
18
|
HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis.
|
Sci Rep
|
2013
|
0.81
|
|
19
|
Protective effect of fucoidan against acetaminophen-induced liver injury.
|
Arch Pharm Res
|
2012
|
0.81
|
|
20
|
Fluorescent phosphoinositide 3-kinase inhibitors suitable for monitoring of intracellular distribution.
|
Bioorg Med Chem
|
2011
|
0.80
|
|
21
|
Development and biological evaluation of potent and selective c-KIT(D816V) inhibitors.
|
J Med Chem
|
2014
|
0.79
|
|
22
|
IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.
|
Cancer Lett
|
2012
|
0.79
|
|
23
|
A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway.
|
Cancer Lett
|
2012
|
0.79
|
|
24
|
Acute restraint-mediated increases in glutamate levels in the rat brain: an in vivo ¹H-MRS study at 4.7 T.
|
Neurochem Res
|
2011
|
0.79
|
|
25
|
Discovery of new azaindole-based PI3Kα inhibitors: apoptotic and antiangiogenic effect on cancer cells.
|
Bioorg Med Chem Lett
|
2010
|
0.78
|
|
26
|
SB365, Pulsatilla saponin D suppresses proliferation and induces apoptosis of pancreatic cancer cells.
|
Oncol Rep
|
2013
|
0.78
|
|
27
|
Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
|
Cancer Lett
|
2012
|
0.78
|
|
28
|
A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
|
Int J Oncol
|
2013
|
0.77
|
|
29
|
Discovery of new benzothiazole-based inhibitors of breakpoint cluster region-Abelson kinase including the T315I mutant.
|
J Med Chem
|
2013
|
0.77
|
|
30
|
Self-fluorescence of chemically crosslinked MRI nanoprobes to enable multimodal imaging of therapeutic cells.
|
Small
|
2012
|
0.76
|
|
31
|
Size-regulated group separation of CoFe2O4 nanoparticles using centrifuge and their magnetic resonance contrast properties.
|
Nanoscale Res Lett
|
2013
|
0.75
|
|
32
|
In vivo Tracking of Human Neural Stem Cells Following Transplantation into a Rodent Model of Ischemic Stroke.
|
Int J Stem Cells
|
2012
|
0.75
|
|
33
|
The effect of HS-111, a novel thiazolamine derivative, on apoptosis and angiogenesis of hepatocellular carcinoma cells.
|
Arch Pharm Res
|
2012
|
0.75
|
|
34
|
Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitor.
|
Int J Oncol
|
2013
|
0.75
|
|
35
|
Uridine-based paramagnetic supramolecular nanoaggregate with high relaxivity capable of detecting primitive liver tumor lesions.
|
Biomaterials
|
2011
|
0.75
|
|
36
|
A DTTA-ligated uridine-quantum dot conjugate as a bimodal contrast agent for cellular imaging.
|
Chem Commun (Camb)
|
2012
|
0.75
|